排闼消癥散通过调控MEK/ERK信号通路对结肠癌侵袭转移的影响OA
Paita Xiaozheng Powder inhibits the invasion and metastasis of colon cancer via regulating the MEK/ERK signaling pathway
目的 探究排闼消癥散对结肠癌侵袭转移的影响及其机制.方法 ①将20 只雄性SD 大鼠随机分为4 组,每组5 只.排闼消癥散低、中、高剂量组分别给予0.5 g/mL、1 g/mL、2 g/mL的排闼消癥散浓缩液2 mL 灌胃,对照组灌胃等量蒸馏水,连续灌胃7d 后取血清.将对数生长期的 HCT-116 细胞(人结肠癌细胞系)接种于24 孔板,然后分为 5 组:对照组予以10%对照组大鼠血清处理24 h,排闼消癥散低、中、高剂量组分别予以10%排闼消癥散低、中、高剂量组大鼠含药血清处理24 h,排闼消癥散高剂量+ML099 组予以10%排闼消癥散高剂量组大鼠含药血清和20 μmol/L丝裂原活化蛋白激酶激酶(MEK)/细胞外信号调节激酶(ERK)信号通路激活剂 ML099 处理24 h.CCK-8 法检测HCT-116 细胞增殖活性,细胞划痕实验和Transwell 小室实验检测HCT-116 细胞的迁移及侵袭能力,Western blot 法检测 HCT-116 细胞中转移相关蛋白 E-钙黏蛋白(E-cadher-in)、N-钙黏蛋白(N-cadherin)、波形蛋白(Vimentin)及 MEK/ERK 信号通路蛋白表达情况.②取12 只 BALB/c nude 裸鼠,采用 HCT-116 细胞接种法构建结肠癌移植瘤模型.肿瘤长出后,将裸鼠随机分为4 组,每组3 只.排闼消癥散低、中、高剂量组分别给予2.53 g/kg、5.06 g/kg、10.12 g/kg排 闼消癥散灌胃,对照组给予等体积蒸馏水灌胃,均1次/d,持续灌胃至HCT-116细胞接种后35 d.灌胃期间,每7d 测量1 次结肠癌移植瘤体积,接种后35 d 取结肠癌移植瘤组织称重,West-ern blot 法和免疫组化法检测结肠癌移植瘤组织中 MEK/ERK 信号通路蛋白表达情况.结果 ①与对照组比较,排闼消癥散各组 HCT-116 细胞增殖活性、划痕愈合率均明显降低(P 均<0.05),细胞迁移数目和侵袭数目均明显减少(P 均<0.05),细胞中 E-cadherin 蛋白相对表达量均明显升高(P 均<0.05),细胞中 N-cadherin、Vimentin 蛋白相对表达量和 p-MEK/MEK、p-ERK/ERK比值均明显降低(P 均<0.05);与排闼消癥散高剂量组比较,排闼消癥散高剂量+ML099 组 HCT-116 细胞增殖活性、划痕愈合率均明显升高(P 均<0.05),细胞迁移数目和侵袭数目均明显增加(P均<0.05),细胞中 E-cadherin 蛋白相对表达量均明显降低(P 均<0.05),细胞中 N-cadherin、Vimentin 蛋白相对表达量和 p-MEK/MEK、p-ERK/ERK 比值均明显升高(P 均<0.05).②与对照组比较,排闼消癥散各组结肠癌移植瘤体积均明显缩小(P 均<0.05),瘤重均明显减轻(P 均<0.05),结肠癌移植瘤组织中 p-MEK/MEK、p-ERK/ERK 比值和 p-MEK、p-ERK 阳性细胞率均明显降低(P 均<0.05).结论 排闼消癥散可以抑制结肠癌侵袭转移,其作用机制可能与调控MEK/ERK 信号通路有关.
Objective It is to explore the effect and mechanism of Paita Xiaozheng Powder(PXP)in inhibiting the in-vasion and metastasis of colon cancer.Methods ①Twenty male SD rats were randomly divided into 4 groups,with 5 rats in each group.The low-dose,medium-dose and high-dose groups of PXP were administered 2 mL of PXP concentrated solu-tion at doses of 0.5 g/mL,1 g/mL,and2 g/mL via gavage,respectively,the control group was administered an equal vol-ume of distilled water via gavage,the serum samples were collected after 7 days of continuous gavage.HCT-116 cells(a human colon cancer cell line)in the logarithmic growth phase were seeded in 24-well plates and then divided into 5 groups:the control group was treated with 10%serum of rats in the control group for 24 h,the low-dose,medium-dose and high-dose groups of PXP were respectively treated with 10%serum containing the drug of rats from the low-dose,medium-dose and high-dose groups of PXP for 24 h,the high-dose PXP+ML099 group was treated with 10%serum of rats from the high-dose group of PXP and 20 μmol/L ML099,a mitogen-activated protein kinase(MEK)/extracellular signal-regulated kinase(ERK)signaling pathway activator,for 24 h.The proliferative activity of HCT-116 cells was detected by CCK-8 as-say;the migration and invasion capabilities of HCT-116 cells were evaluated by cell scratch assay and the Transwell assay,and the protein expressions of metastasis-related proteins in HCT-116 cells,including E-cadherin,N-cadherin,vimentin,and MEK/ERK signaling pathway proteins were detected by Western blot.②Twelve BALB/c nude mice were prepared with HCT-116 cell implantation method to establish colon cancer xenograft models.Once the tumors had developed,the nude mice were randomly divided into 4 groups,with 3 mice in each group.The low-dose,medium-dose and high-dose groups of PXP were administered 2.53 g/kg,5.06 g/kg,and 10.12 g/kg of PXP via gavage,respectively,the control group was given an equal volume of distilled water via gavage,all once daily,continuously treated until 35 days after HCT-116 cell implantation.During the gavage period,the volume of the colon cancer xenograft was measured once every 7 days.In 35 days after implantation,the colon cancer xenograft tissue was harvested and weighed,and the expressions of proteins in the MEK/ERK signaling pathway in the xenograft tissue were detected by Western blot and immunohistochemistry.Results ①Compared with the control group,the cell proliferation activities and scratch healing rates of HCT-116 cells in each dose groups of PXP,as well as the number of migrating and invading cells were significantly decreased(all P<0.05),the rela-tive protein expressions of E-cadherin in the cells were significantly increased(all P<0.05),while the relative protein ex-pressions of N-cadherin and vimentin,as well as the p-MEK/MEK and p-ERK/ERK ratios were significantly decreased(all P<0.05).Compared with the high-dose PXP group,the cell proliferation activity and scratch healing rate of HCT-116 cells in the high-dose PXP+ML099 group,as well as the number of migrating and invading cells were significantly in-creased(all P<0.05),the relative protein expression of E-cadherin in the cells was significantly reduced(P<0.05),while the relative protein expressions of N-cadherin and vimentin,as well as the p-MEK/MEK and p-ERK/ERK ratios were significantly increased(all P<0.05).②Compared with the control group,the volume and tumor weight of colon cancer xenografts in each dose group of PXP were significantly reduced(all P<0.05),and the p-MEK/MEK and p-ERK/ERK ratios,as well as the percentages of p-MEK-and p-ERK-positive cells in the colon cancer xenograft tissue were all signifi-cantly reduced(all P<0.05).Conclusion PXP can inhibit the invasion and metastasis of colon cancer,and its mecha-nism of action may be related to the regulation of MEK/ERK signaling pathway.
伊凡;周铭心;杨俊玲;王芳;姜文锡
乌鲁木齐市中医医院,新疆 乌鲁木齐 830000乌鲁木齐市中医医院,新疆 乌鲁木齐 830000乌鲁木齐市中医医院,新疆 乌鲁木齐 830000乌鲁木齐市中医医院,新疆 乌鲁木齐 830000乌鲁木齐市中医医院,新疆 乌鲁木齐 830000
医药卫生
排闼消癥散结肠癌侵袭转移丝裂原活化蛋白激酶激酶细胞外信号调节激酶
Paita Xiaozheng Powdercolon cancerproliferationmetastasismitogen-activated protein kinaseextra-cellular signal-regulated kinase
《现代中西医结合杂志》 2026 (13)
1785-1792,8
乌鲁木齐市中医药科技创新项目(ZYYZD-04)
评论